Financial News
Latest News about Partner Content
Recent news which mentions Partner Content
How FiscalNote (NYSE: NOTE) Is Empowering AI Integration For Governing Bodies Around The World
September 14, 2023
Tickers
NOTE
From Benzinga
HEVI's Line Of All-Electric Excavators And Loaders Finally Brings A Zero Emission Alternative To Diesel-Powered Heavy Equipment
September 14, 2023
From Benzinga
Is The Age Of Solar Upon Us? How SolarBank Plans To Capitalize On The Rise Of Solar Power
September 14, 2023
From Benzinga
Pivot To Agri-Food Sector Pays Off For Sadot Group, Inc As Company Reports First Profitable Quarter In Q2 2023
September 14, 2023
Tickers
SDOT
From Benzinga
From Benzinga
What's Spurring The Growth Of The Psychedelics Market – And How One Company Is Helping As Part Of The Vanguard In This Emerging Field
September 12, 2023
Tickers
CMPS
From Benzinga
The Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB:OTLC) Is Leading The Charge
September 11, 2023
Tickers
OTLC
From Benzinga
Bitcoin Vs. Seasonal Tokens: Navigating The Crypto Halving Landscape In 2024
September 11, 2023
From Benzinga
Ambow Education's (NYSE: AMBO) Innovative HybriU AI Digital Education Solution Showcases The Potential Of AI To Transform Education
September 11, 2023
From Benzinga
Should You Trust Lear Capital With Your Precious Metals Investments?
September 11, 2023
From Benzinga
How Robinhood's Mobile-First 24-5 Trading Cycle Is Helping Redefine Trading By Letting Traders Manage Their Portfolios Anytime, Anywhere
September 11, 2023
From Benzinga
The Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB: OTLC) Is Helping Lead The Charge
September 11, 2023
Tickers
OTLC
From Benzinga
LFP Technology Adoption Is On The Rise, And It's Powered By Phosphate – This Company Could Help Achieve Supply Independence For This Critical Mineral
September 11, 2023
From Benzinga
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
From Benzinga
Wallabing Is The Airbnb Of RVs Without The High Fees – And It's Already Raised Over $55,000 On Wefunder
September 11, 2023
From Benzinga
From Benzinga
Cybersecurity Tech Company Sekur Reports Increased Traffic And Conversion Rates After Launching Revamped Website
September 07, 2023
From Benzinga
Seasonal Tokens Vs. Litecoin: Navigating Crypto Halvings In 2023
September 06, 2023
From Benzinga
FiscalNote (NYSE: NOTE) Accelerates Towards Profitability As Q2 Earnings Showcase Healthy Revenue Growth, Expects Adjusted EBITDA Profitability Earlier Than Expected
September 06, 2023
From Benzinga
The Best AI PR Agencies You Must Know
September 06, 2023
From Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
From Benzinga
Trading The Nasdaq 100 To Capitalize On The Tech Rally This Year? You May Want To Check Out This ETF Instead
September 06, 2023
From Benzinga
Is Rekor Systems (NASDAQ: REKR), A Company Bringing AI To A Largely Untapped Market, On Your Watchlist?
September 05, 2023
Tickers
REKR
From Benzinga
Cboe Q2 Net Revenue Up By Double Digits Driven By Strong Growth In Options Business
September 05, 2023
Tickers
CBOE
From Benzinga
10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar
September 05, 2023
From Benzinga
From Benzinga
IPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis – Could GRI-0621 Be The Solution?
August 31, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
